# Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML

> **NCT06724536** · — · RECRUITING · sponsor: **Carmen Fava** · enrollment: 100 (estimated)

## Conditions studied

- Leukemia,Myeloid, Chronic

## Interventions

- **OTHER:** non interventional study with the use of biological samples.

## Key facts

- **NCT ID:** NCT06724536
- **Lead sponsor:** Carmen Fava
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06724536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06724536, "Interaction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CML". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06724536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*